R Caruso, F Alesiani and R Latagliata (1997) “Prolonged low doses of oral etoposide may be effective in individual patients with advanced lymphoproliferative disorders refractory to aggressive chemotherapy”, Haematologica. Pavia, Italy, 82(1), pp. 126-127. doi: 10.3324/%x.